{
  "author": {
    "name": "Liz Szabo Kaiser Health News",
    "webUrl": "/author/profile/liz-szabo-kaiser-health-news/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 6,
    "social": [],
    "articles": [
      {
        "uri": "/2020/09/03/are-americans-ready-for-a-covid-19-vaccine/",
        "title": "Is America ready for a COVID-19 vaccine?",
        "byline": "Liz Szabo, Kaiser Health News",
        "kicker": "News",
        "prettyDate": "September 03, 2020",
        "timeToRead": "11 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2020/07/Injection-Article-202007222110.jpg",
          "width": "0",
          "height": "0"
        },
        "authors": [
          {
            "webUrl": "/author/profile/liz-szabo-kaiser-health-news/",
            "name": "Liz Szabo, Kaiser Health News"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "The CDC's has told governors to have vaccine distribution sites up and running by Nov. 1, but there's a lot more work to be done.",
        "body": null
      },
      {
        "uri": "/2019/12/31/artificial-intelligence-and-health-care-the-revolution-has-not-yet-come/",
        "title": "Artificial intelligence and health care: The revolution has not yet come",
        "byline": "Liz Szabo, Kaiser Health News",
        "kicker": "Market Insights",
        "prettyDate": "December 31, 2019",
        "timeToRead": "13 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/02/MedicalTech.jpg",
          "width": "600",
          "height": "400"
        },
        "authors": [
          {
            "webUrl": "/author/profile/liz-szabo-kaiser-health-news/",
            "name": "Liz Szabo, Kaiser Health News"
          }
        ],
        "kickerNode": [
          {
            "uri": "/market-insights/",
            "sectionName": "Market Insights"
          }
        ],
        "summary": "Many doctors and consumer advocates fear that the tech industry, which lives by the mantra \"fail fast and fix it later,\" is putting patients at risk.",
        "body": null
      },
      {
        "uri": "/2019/06/26/can-employers-save-money-with-stem-cell-therapy/",
        "title": "Can employers save money with stem cell therapy?",
        "byline": "Liz Szabo, Kaiser Health News",
        "kicker": "Investigation",
        "prettyDate": "June 26, 2019",
        "timeToRead": "12 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/04/DrugVials.jpg",
          "width": "600",
          "height": "400"
        },
        "authors": [
          {
            "webUrl": "/author/profile/liz-szabo-kaiser-health-news/",
            "name": "Liz Szabo, Kaiser Health News"
          }
        ],
        "kickerNode": [
          {
            "uri": "/investigation/",
            "sectionName": "Investigation"
          }
        ],
        "summary": "Hundreds of employers now include stem cell therapy in their insurance coverage, but is it worth the cost? ",
        "body": null
      },
      {
        "uri": "/2018/11/06/precision-medicine-worth-the-expense/",
        "title": "Precision medicine: worth the expense?",
        "byline": "Liz Szabo, Kaiser Health News",
        "kicker": "Market Insights",
        "prettyDate": "November 06, 2018",
        "timeToRead": "7 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/04/DrugVials.jpg",
          "width": "600",
          "height": "400"
        },
        "authors": [
          {
            "webUrl": "/author/profile/liz-szabo-kaiser-health-news/",
            "name": "Liz Szabo, Kaiser Health News"
          }
        ],
        "kickerNode": [
          {
            "uri": "/market-insights/",
            "sectionName": "Market Insights"
          }
        ],
        "summary": "The high cost of cutting-edge tests and treatments is threatening to keep precision medicine out of reach for many patients.",
        "body": null
      },
      {
        "uri": "/2017/10/23/unneeded-tests-outdated-treatments-adding-to-patie/",
        "title": "Unneeded tests, outdated treatments adding to patients' woes",
        "byline": " Liz Szabo, Kaiser Health News ",
        "kicker": "",
        "prettyDate": "October 23, 2017",
        "timeToRead": "11 minute",
        "image": {
          "uri": "",
          "width": "",
          "height": ""
        },
        "authors": [
          {
            "webUrl": "/author/profile/liz-szabo-kaiser-health-news/",
            "name": "Liz Szabo, Kaiser Health News"
          }
        ],
        "kickerNode": [],
        "summary": "An exclusive analysis for Kaiser Health News found that only 48 percent of eligible breast cancer patients today get a recommended shorter radiation regimen, in spite of the additional costs and inconvenience of the longer type.",
        "body": null
      },
      {
        "uri": "/2017/10/18/1-million-per-person-cancer-treatments-coming/",
        "title": "$1 million (per person) cancer treatments coming",
        "byline": "Liz Szabo, Kaiser Health News",
        "kicker": "",
        "prettyDate": "October 18, 2017",
        "timeToRead": "7 minute",
        "image": {
          "uri": "",
          "width": "",
          "height": ""
        },
        "authors": [
          {
            "webUrl": "/author/profile/liz-szabo-kaiser-health-news/",
            "name": "Liz Szabo, Kaiser Health News"
          }
        ],
        "kickerNode": [],
        "summary": "Costs for CAR T-cell therapies will be far higher than many have imagined, reaching $1 million or more per patient, according to leading cancer experts. The next CAR T-cell drug could be approved as soon as November.",
        "body": null
      }
    ]
  }
}